Classical endocannabinoid-like compounds and their regulation by nutrients

BioFactors

Volumn 40, Issue 4, 2014, Pages 363-372

  Kleberg, Karen ^a   Hassing, Helle A ^a   Hansen, Harald S ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

2 oleoylglycerol; Dietary fat; Monoacylglycerol; N acylethanolamine; Oleoylethanolamide

Indexed keywords

2 MONOACYLGLYCEROL DERIVATIVE; 2 OLEOYLGLYCEROL; 2 PALMITOYLGLYCEROL; ENDOCANNABINOID; GLYCEROL DERIVATIVE; LIPOPROTEIN; N ACYLETHANOLAMINE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; UNCLASSIFIED DRUG; ETHANOLAMINE DERIVATIVE; MONOACYLGLYCEROL; N-ACYLETHANOLAMINES;

APPETITE; BIOSYNTHESIS; ENTEROENDOCRINE CELL; ENZYME DEGRADATION; ENZYME SYNTHESIS; FOOD INTAKE; HORMONE RELEASE; HUMAN; LIPID DIET; LIPOLYSIS; NUTRIENT; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SMALL INTESTINE; VAGUS NERVE; ANIMAL; DIET; EATING; HYPERPHAGIA; LIPID METABOLISM; METABOLISM; NUTRITIONAL STATUS; PHYSIOLOGY;

ANIMALS; DIET; EATING; ENDOCANNABINOIDS; ETHANOLAMINES; HUMANS; HYPERPHAGIA; LIPID METABOLISM; MONOGLYCERIDES; NUTRITIONAL STATUS;

EID: 84906790704     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1158     Document Type: Review

References (129)

1. Bellocchio, L., Cervino, C., Pasquali, R., and Pagotto, U. (2008) The endocannabinoid system and energy metabolism. J. Neuroendocrinol. 20, 850-857.
2. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., et al. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
3. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., et al. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83-90.
4. Gaoni, Y. and Mechoulam, R. (1964) Isolation, structure, and partial synthesis of an active constituent of Hashish. J. Am. Chem. Soc. 86, 1646-1647.
5. Makriyannis, A., Mechoulam, R., and Piomelli, D. (2005) Therapeutic opportunities through modulation of the endocannabinoid system. Neuropharmacology 48, 1068-1071.
6. Ghafouri, N., Tiger, G., Razdan, R. K., Mahadevan, A., Pertwee, R. G., et al. (2004) Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol. Br. J. Pharmacol. 143, 774-784.
7. Ben-Shabat, S., Fride, E., Sheskin, T., Tamiri, T., Rhee, M. H., et al. (1998) An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. Eur. J. Pharmacol. 353, 23-31.
8. Hansen, H. S., Rosenkilde, M. M., Holst, J. J., and Schwartz, T. W. (2012) GPR119 as a fat sensor. Trends Pharmacol. Sci. 33, 374-381.
9. Petersen, G., Sorensen, C., Schmid, P. C., Artmann, A., Tang-Christensen, M., et al. (2006) Intestinal levels of anandamide and oleoylethanolamide in food-deprived rats are regulated through their precursors. Biochim. Biophys. Acta 1761, 143-150.
10. Artmann, A., Petersen, G., Hellgren, L. I., Boberg, J., Skonberg, C., et al. (2008) Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim. Biophys. Acta 1781, 200-212.
11. Diep, T. A., Madsen, A. N., Holst, B., Kristiansen, M. M., Wellner, N., et al. (2011) Dietary fat decreases intestinal levels of the anorectic lipids through a fat sensor. FASEB J. 25, 765-774.
12. Tellez, L. A., Medina, S., Han, W., Ferreira, J. G., Licona-Limon, P., et al. (2013) A gut lipid messenger links excess dietary fat to dopamine deficiency. Science 341, 800-802.
13. Schwartz, G. J., Fu, J., Astarita, G., Li, X., Gaetani, S., et al. (2008) The lipid messenger OEA links dietary fat intake to satiety. Cell Metab. 8, 281-288.
14. Thomsen, C., Rasmussen, O., Lousen, T., Holst, J. J., Fenselau, S., et al. (1999) Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects. Am. J. Clin. Nutr. 69, 1135-1143.
15. Sanders, T. A., Filippou, A., Berry, S. E., Baumgartner, S., and Mensink, R. P. (2011) Palmitic acid in the sn-2 position of triacylglycerols acutely influences postprandial lipid metabolism. Am. J. Clin. Nutr. 94, 1433-1441.
16. Suzuki, S., Ishikawa, S., Arihara, K., and Itoh, M. (2008) Molecular species-specific differences in composition of triacylglycerols of mouse adipose tissue and diet. Nutr. Res. 28, 258-262.
17. Wainwright, C. L. and Michel, L. (2013) Endocannabinoid system as a potential mechanism for n-3 long-chain polyunsaturated fatty acid mediated cardiovascular protection. Proc. Nutr. Soc. 72, 460-469.
18. Hanus, L., Gopher, A., Almog, S., and Mechoulam, R. (1993) Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor. J. Med. Chem. 36, 3032-3034.
19. Tan, B., O'Dell, D. K., Yu, Y. W., Monn, M. F., Hughes, H. V., et al. (2010) Identification of endogenous acyl amino acids based on a targeted lipidomics approach. J. Lipid Res. 51, 112-119.
20. Hansen, H. S. (2010) Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain. Exp. Neurol. 224, 48-55.
21. Kuehl, F. A., Jacob, T. A., Ganley, O. H., Ormond, R. E., and Meisinger, M. A. P. (1957) The identification of N-(2-hydroxyethyl)-palmitamide as a naturally occuring anti-inflammatory agent. J. Am. Chem. Soc. 79, 5577-5578.
22. Buczynski, M. W., Svensson, C. I., Dumlao, D. S., Fitzsimmons, B. L., Shim, J. H., et al. (2010) Inflammatory hyperalgesia induces essential bioactive lipid production in the spinal cord. J. Neurochem. 114, 981-993.
23. Srisai, D., Gillum, M. P., Panaro, B. L., Zhang, X. M., Kotchabhakdi, N., et al. (2011) Characterization of the hyperphagic response to dietary fat in the MC4R knockout mouse. Endocrinology 152, 890-902.
24. Piomelli, D. (2014) More surprises lying ahead. The endocannabinoids keep us guessing. Neuropharmacology 76, 228-234.
25. Schmid, H. H., Schmid, P. C., and Natarajan, V. (1990) N-acylated glycerophospholipids and their derivatives. Prog. Lipid Res. 29, 1-43.
26. Wellner, N., Diep, T. A., Janfelt, C., and Hansen, H. S. (2013) N-acylation of phosphatidylethanolamine and its biological functions in mammals. Biochim. Biophys. Acta 1831, 652-662.
27. Ueda, N., Tsuboi, K., and Uyama, T. (2013) Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways. FEBS J. 280, 1874-1894.
28. Hansen, H. S., Moesgaard, B., Hansen, H. H., and Petersen, G. (2000) N-Acylethanolamines and precursor phospholipids - relation to cell injury. Chem. Phys. Lipids 108, 135-150.
29. Uyama, T., Inoue, M., Okamoto, Y., Shinohara, N., Tai, T., et al. (2013) Involvement of phospholipase A/acyltransferase-1 in N-acylphosphatidylethanolamine generation. Biochim. Biophys. Acta 1831, 1690-1701.
30. Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., and Ueda, N. (2004) Molecular characterization of a phospholipase D generating anandamide and its congeners. J.Biol.Chem. 279, 5298-5305.
31. Hansen, H. S., Diep, T. A. (2009) N-acylethanolamines, anandamide and food intake. Biochem.Pharmacol. 78, 553-560.
32. Schmid, P. C., Reddy, P. V., Natarajan, V., Schmid, H. H. (1983) Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type. J. Biol. Chem. 258, 9302-9306.
33. Leung, D., Saghatelian, A., Simon, G. M., and Cravatt, B. F. (2006) Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids. Biochemistry 45, 4720-4726.
34. Tsuboi, K., Okamoto, Y., Ikematsu, N., Inoue, M., Shimizu, Y., et al. (2011) Enzymatic formation of N-acylethanolamines from N-acylethanolamine plasmalogen through N-acylphosphatidylethanolamine-hydrolyzing phospholipase D-dependent and -independent pathways. Biochim. Biophys. Acta 1811, 565-577.
35. Fu, J., Gaetani, S., Oveisi, F., Lo, V. J., Serrano, A., et al. (2003) Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 425, 90-93.
36. Morishita, J., Okamoto, Y., Tsuboi, K., Ueno, M., Sakamoto, H., et al. (2005) Regional distribution and age-dependent expression of N-acylphosphatidylethanolamine-hydrolyzing phospholipase D in rat brain. J. Neurochem. 94, 753-762.
37. Moesgaard, B., Petersen, G., Mortensen, S. A., and Hansen, H. S. (2002) Substantial species differences in relation to formation and degradation of N-acyl-ethanolamine phospholipids in heart tissue: an enzyme activity study. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 131, 475-482.
38. Wang, J., Okamoto, Y., Tsuboi, K., and Ueda, N. (2008) The stimulatory effect of phosphatidylethanolamine on N-acylphosphatidylethanolamine-hydrolyzing phospholipase D (NAPE-PLD). Neuropharmacology 54, 8-15.
39. Petersen, G., Pedersen, A. H., Pickering, D. S., Begtrup, M., and Hansen, H. S. (2009) Effect of synthetic and natural phospholipids on N-acylphosphatidylethanolamine-hydrolyzing phospholipase D activity. Chem. Phys. Lipids 162, 53-61.
40. Kilaru, A., Tamura, P., Isaac, G., Welti, R., Venables, B. J., et al. (2012) Lipidomic analysis of N-acylphosphatidylethanolamine molecular species in Arabidopsis suggests feedback regulation by N-acylethanolamines. Planta 236, 809-824.
41. Simon, G. M. and Cravatt, B. F. (2006) Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway. J. Biol. Chem. 281, 26465-26472.
42. Simon, G. M. and Cravatt, B. F. (2008) Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain. J. Biol. Chem. 283, 9341-9349.
43. Liu, J., Wang, L., Harvey-White, J., Osei-Hyiaman, D., Razdan, R., et al. (2006) A biosynthetic pathway for anandamide. Proc. Natl. Acad. Sci. USA 103, 13345-13350.
44. Liu, J., Wang, L., Harvey-White, J., Huang, B. X., Kim, H. Y., et al. (2008) Multiple pathways involved in the biosynthesis of anandamide. Neuropharmacology 54, 1-7.
45. Schmid, P. C., Krebsbach, R. J., Perry, S. R., Dettmer, T. M., Maasson, J. L., et al. (1995) Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain. FEBS Lett. 375, 117-120.
46. Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., et al. (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. USA 98, 9371-9376.
47. Kathuria, S., Gaetani, S., Fegley, D., Valino, F., Duranti, A., et al. (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat. Med. 9, 76-81.
48. Lichtman, A. H., Leung, D., Shelton, C. C., Saghatelian, A., Hardouin, C., et al. (2004) Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity. J. Pharmacol. Exp. Ther. 311, 441-448.
49. Desarnaud, F., Cadas, H., and Piomelli, D. (1995) Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. J. Biol. Chem. 270, 6030-6035.
50. Katayama, K., Ueda, N., Kurahashi, Y., Suzuki, H., Yamamoto, S., et al. (1997) Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine. Biochim. Biophys. Acta 1347, 212-218.
51. Ueda, N., Kurahashi, Y., Yamamoto, S., and Tokunaga, T. (1995) Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. J. Biol. Chem. 270, 23823-23827.
52. Fegley, D., Gaetani, S., Duranti, A., Tontini, A., Mor, M., et al. (2005) Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J. Pharmacol. Exp. Ther. 313, 352-358.
53. Okine, B. N., Norris, L. M., Woodhams, S., Burston, J., Patel, A., et al. (2012) Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system. Br. J. Pharmacol. 167, 627-640.
54. Starowicz, K., Makuch, W., Korostynski, M., Malek, N., Slezak, M., et al. (2013) Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism. PLoS One 8, e60040.
55. Maione, S., Costa, B., Piscitelli, F., Morera, E., De Chiaro M., et al. (2013) Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics. Pharmacol. Res. 76, 98-105.
56. Ueda, N., Yamanaka, K., and Yamamoto, S. (2001) Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance. J. Biol. Chem. 276, 35552-35557.
57. Tsuboi, K., Sun, Y. X., Okamoto, Y., Araki, N., Tonai, T., et al. (2005) Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase. J. Biol. Chem. 280, 11082-11092.
58. Tai, T., Tsuboi, K., Uyama, T., Masuda, K., Cravatt, B. F., et al. (2012) Endogenous molecules stimulating N-acylethanolamine-hydrolyzing acid amidase (NAAA). ACS Chem. Neurosci. 3, 379-385.
59. Li, Y., Yang, L., Chen, L., Zhu, C., Huang, R., et al. (2012) Design and synthesis of potent N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds. PLoS One 7, e43023.
60. Ponzano, S., Bertozzi, F., Mengatto, L., Dionisi, M., Armirotti, A., et al. (2013) Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors. J. Med. Chem. 56, 6917-6934.
61. West, J. M., Zvonok, N., Whitten, K. M., Vadivel, S. K., Bowman, A. L., et al. (2012) Biochemical and mass spectrometric characterization of human N-acylethanolamine-hydrolyzing acid amidase inhibition. PLoS One 7, e43877.
62. Yamano, Y., Tsuboi, K., Hozaki, Y., Takahashi, K., Jin, X. H., et al. (2012) Lipophilic amines as potent inhibitors of N-acylethanolamine-hydrolyzing acid amidase. Bioorg. Med. Chem. 20, 3658-3665.
63. Skonberg, C., Artmann, A., Cornett, C., Hansen, S. H., and Hansen, H. S. (2010) Pitfalls in the sample preparation and analysis of N-acylethanolamines. J. Lipid Res. 51, 3062-3073.
64. Hansen, H. S. (2013) Effect of diet on tissue levels of palmitoylethanolamide. CNS Neurol. Disord. Drug Targets 12, 17-25.
65. Syed, S. K., Bui, H. H., Beavers, L. S., Farb, T. B., Ficorilli, J., et al. (2012) Regulation of GPR119 receptor activity with endocannabinoid-like lipids. Am. J. Physiol. Endocrinol. Metab. 303, E1469-E1478.
66. Guzman, M., Lo, V. J., Fu, J., Oveisi, F., Blazquez, C., et al. (2004) Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha). J. Biol. Chem. 279, 27849-27854.
67. LoVerme, J., Guzman, M., Gaetani, S., and Piomelli, D. (2006) Cold exposure stimulates synthesis of the bioactive lipid oleoylethanolamide in rat adipose tissue. J. Biol. Chem. 281, 22815-22818.
68. Deblon, N., Veyrat-Durebex, C., Bourgoin, L., Caillon, A., Bussier, A. L., et al. (2011) Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. PLoS One 6, e25565.
69. LoVerme, J., Fu, J., Astarita, G., La Rana, G., Russo, R., et al. (2005) The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol. Pharmacol. 67, 15-19.
70. Long, J. Z., LaCava, M., Jin, X., and Cravatt, B. F. (2011) An anatomical and temporal portrait of physiological substrates for fatty acid amide hydrolase. J. Lipid Res. 52, 337-344.
71. Sasso, O., Moreno-Sanz, G., Martucci, C., Realini, N., Dionisi, M., et al. (2013) Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models. Pain 154, 350-360.
72. De Filippis, D., D'Amico, A., Cipriano, M., Petrosino, S., Orlando, P., et al. (2010) Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats. Pharmacol. Res. 61, 321-328.
73. Panlilio, L. V., Justinova, Z., and Goldberg, S. R. (2013) Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction. Pharmacol. Ther. 138, 84-102.
74. Fu, J., Astarita, G., Gaetani, S., Kim, J., Cravatt, B. F., et al. (2007) Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine. J. Biol. Chem. 282, 1518-1528.
75. Izzo, A. A., Piscitelli, F., Capasso, R., Marini, P., Cristino, L., et al. (2010) Basal and fasting/refeeding-regulated tissue levels of endogenous PPAR-alpha ligands in Zucker rats. Obesity (Silver Spring) 18, 55-62.
76. Rodriguez de Fonseca, F., Navarro, M., Gomez, R., Escuredo, L., Nava, F., et al. (2001) An anorexic lipid mediator regulated by feeding. Nature 414, 209-212.
77. Fu, J., Kim, J., Oveisi, F., Astarita, G., and Piomelli, D. (2008) Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R45-R50.
78. Overton, H. A., Babbs, A. J., Doel, S. M., Fyfe, M. C. T., Gardner, L. S., et al. (2006) Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab. 3, 167-175.
79. Ho, W. S., Barrett, D. A., and Randall, M. D. (2008) 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. Br. J. Pharmacol. 155, 837-846.
80. Voitychuk, O. I., Asmolkova, V. S., Gula, N. M., Sotkis, G. V., Galadari, S., et al. (2012) Modulation of excitability, membrane currents and survival of cardiac myocytes by N-acylethanolamines. Biochim. Biophys. Acta 1821, 1167-1176.
81. Amoros, I., Barana, A., Caballero, R., Gomez, R., Osuna, L., et al. (2010) Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent manner. J. Mol. Cell Cardiol. 48, 201-210.
82. Barana, A., Amoros, I., Caballero, R., Gomez, R., Osuna, L., et al. (2010) Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner. Cardiovasc. Res. 85, 56-67.
83. Odori, S., Hosoda, K., Tomita, T., Fujikura, J., Kusakabe, T., et al. (2013) GPR119 expression in normal human tissues and islet cell tumors: evidence for its islet-gastrointestinal distribution, expression in pancreatic beta and alpha cells, and involvement in islet function. Metabolism 62, 70-78.
84. Lauffer, L. M., Iakoubov, R., and Brubaker, P. L. (2009) GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Diabetes 58, 1058-1066.
85. Chu, Z. L., Carroll, C., Chen, R., Alfonso, J., Gutierrez, V., et al. (2010) N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119. Mol.Endocrinol. 24, 161-170.
86. Stone, V. M., Dhayal, S., Smith, D. M., Lenaghan, C., Brocklehurst, K. J., et al. (2012) The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119. Br. J. Pharmacol. 165, 2758-2770.
87. Moesgaard, B., Jaroszewski, J. W., and Hansen, H. S. (1999) Accumulation of N-acyl-ethanolamine phospholipids in rat brains during post-decapitative ischemia: a 31p NMR study. J. Lipid Res. 40, 515-521.
88. Hansen, H. H., Ikonomidou, C., Bittigau, P., Hansen, S. H., and Hansen, H. S. (2001) Accumulation of the anandamide precursor and other N-acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death. J. Neurochem. 76, 39-46.
89. Janfelt, C., Wellner, N., Leger, P. L., Kokesch-Himmelreich, J., Hansen, S. H., et al. (2012) Visualization by mass spectrometry of 2-dimensional changes in rat brain lipids, including N-acylphosphatidylethanolamines, during neonatal brain ischemia. FASEB J. 26, 2667-2673.
90. Natarajan, V., Schmid, P. C., Reddy, P. V., Zuzarte-Augustin, M. L., and Schmid, H. H. (1985) Occurrence of N-acylethanolamine phospholipids in fish brain and spinal cord. Biochim. Biophys. Acta 835, 426-433.
91. Hansen, H. H., Schmid, P. C., Bittigau, P., Lastres-Becker, I., Berrendero, F., et al. (2001) Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. J. Neurochem. 78, 1415-1427.
92. Degn, M., Lambertsen, K. L., Petersen, G., Meldgaard, M., Artmann, A., et al. (2007) Changes in brain levels of N-acylethanolamines and 2-arachidonoylglycerol in focal cerebral ischemia in mice. J. Neurochem. 103, 1907-1916.
93. Berger, C., Schmid, P. C., Schabitz, W. R., Wolf, M., Schwab, S., et al. (2004) Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia? J. Neurochem. 88, 1159-1167.
94. Mu, H. and Høy, C. E. (2004) The digestion of dietary triacylglycerols. Progr. Lipid Res. 43, 105-133.
95. Young, S. G. and Zechner, R. (2013) Biochemistry and pathophysiology of intravascular and intracellular lipolysis. Genes Dev. 27, 459-484.
96. Hansen, K. B., Rosenkilde, M. M., Knop, F. K., Wellner, N., Diep, T. A., et al. (2011) 2-oeloylglycerol is a GPR119 agonist and signals GLP-1 release in humans. J. Clin. Endocrinol. Metab. 96, E1409-E1417.
97. Zhao, S., Iglesias, J., Mugabo, Y., Peyot, M. L., Joly, E., et al. (2013) Monoacylglycerol as a metabolic coupling factor in glucose-stimulated insulin secretion. Can. J. Diabetes 37, 62.
98. Prentki, M., Matschinsky, F. M., and Madiraju, S. R. (2013) Metabolic signaling in fuel-induced insulin secretion. Cell Metab. 18, 162-185.
99. Rodriguez, J. A., Mendoza, L. D., Pezzotti, F., Vanthuyne, N., Leclaire, J., et al. (2008) Novel chromatographic resolution of chiral diacylglycerols and analysis of the stereoselective hydrolysis of triacylglycerols by lipases. Anal. Biochem. 375, 196-208.
100. DeNigris, S. J., Hamosh, M., Kasbekar, D. K., Lee, T. C., and Hamosh, P. (1988) Lingual and gastric lipases: species differences in the origin of prepancreatic digestive lipases and in the localization of gastric lipase. Biochim. Biophys. Acta 959, 38-45.
101. Kawai, T. and Fushiki, T. (2003) Importance of lipolysis in oral cavity for orosensory detection of fat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, R447-R454.
102. Pepino, M. Y., Love-Gregory, L., Klein, S., and Abumrad, N. A. (2011) The fatty acid translocase gene, CD36, and lingual lipase influence oral sensitivity to fat in obese subjects. J. Lipid Res. 53, 561-566.
103. Stewart, J. E., Feinle-Bisset, C., Golding, M., Delahunty, C., Clifton, P. M., et al. (2010) Oral sensitivity to fatty acids, food consumption and BMI in human subjects. Br. J. Nutr. 104, 145-152.
104. Aloulou, A. and Carrière, F. (2008) Gastric lipase: an extremophilic interfacial enzyme with medical applications. Cell Mol Life Sci. 65, 851-854.
105. Mu, H. and Porsgaard, T. (2005) The metabolism of structured triacylglycerols. Progr. Lipid Res. 44, 430-448.
106. Perona, J. S., Portillo, M. P., Teresa, M. M., Tueros, A. I., and Ruiz-Gutierrez, V. (2000) Influence of different dietary fats on triacylglycerol deposition in rat adipose tissue. Br. J. Nutr. 84, 765-774.
107. Berry, S. E. (2009) Triacylglycerol structure and interesterification of palmitic and stearic acid-rich fats: an overview and implications for cardiovascular disease. Nutr. Res. Rev. 22, 3-17.
108. Kindel, T., Lee, D. M., and Tso, P. (2010) The mechanism of the formation and secretion of chylomicrons. Atheroscler. Suppl. 11, 11-16.
109. Pan, X. and Hussain, M. M. (2012) Gut triglyceride production. Biochim. Biophys. Acta 1821, 727-735.
110. Lyubachevskaya, G. and Boyle-Roden, E. (2000) Kinetics of 2-monoacylglycerol acyl migration in model chylomicra. Lipids 35, 1353-1358.
111. Nilsson-Ehle, P., Garfinkel, A. S., and Schotz, M. C. (1974) Positional specificity of adipose tissue lipoprotein lipase. Lipids 9, 548-553.
112. Nilsson-Ehle, P., Egelrud, T., Belfrage, P., Olivecrona, T., and Borgstrom, B. (1973) Positional specificity of purified milk lipoprotein lipase. J. Biol. Chem. 248, 6734-6737.
113. Nilsson-Ehle, P., Belfrage, P., and Borgstrom, B. (1971) Purified human lipoprotein lipase: positional specificity. Biochim. Biophys. Acta 248, 114-120.
114. Thomas, G., Betters, J. L., Lord, C. C., Brown, A. L., Marshall, S., et al. (2013) The serine hydrolase ABHD6 Is a critical regulator of the metabolic syndrome. Cell Rep. 5, 508-520.
115. Zechner, R., Zimmermann, R., Eichmann, T. O., Kohlwein, S. D., Haemmerle, G., et al. (2012) Fat signals-lipases and lipolysis in lipid metabolism and signaling. Cell Metab. 15, 279-291.
116. Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., et al. (2003) Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J. Cell Biol. 163, 463-468.
117. Kawashima, M., Iwamoto, N., Kawaguchi-Sakita, N., Sugimoto, M., Ueno, T., et al. (2013) High-resolution imaging mass spectrometry reveals detailed spatial distribution of phosphatidylinositols in human breast cancer. Cancer Sci. 104, 1372-1379.
118. Labar, G., Wouters, J., and Lambert, D. M. (2010) A review on the monoacylglycerol lipase: at the interface between fat and endocannabinoid signalling. Curr. Med. Chem. 17, 2588-2607.
119. Marrs, W. R., Blankman, J. L., Horne, E. A., Thomazeau, A., Lin, Y. H., et al. (2010) The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nat. Neurosci. 13, 951-957.
120. Soga, T., Ohishi, T., Matsui, T., Saito, T., Matsumoto, M., et al. (2005) Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem. Biophys. Res. Commun. 326, 744-751.
121. Overton, H. A., Fyfe, M. C., and Reynet, C. (2008) GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity. Br. J. Pharmacol. 153(Suppl 1), S76-S81.
122. Pertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P., Di Marzo, V., et al. (2010) International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB(1) and CB(2). Pharmacol. Rev. 62, 588-631.
123. Flock, G., Holland, D., Seino, Y., and Drucker, D. J. (2011) GPR119 regulates murine glucose homeostasis through incretin receptor-dependent and independent mechanisms. Endocrinology 152, 374-383.
124. Lan, H., Lin, H., Wang, C., Wright, M., Xu, S., et al. (2012) Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways. Br. J. Pharmacol. 165, 2799-2807.
125. Lan, H., Vassileva, G., Corona, A., Liu, L., Baker, H., et al. (2009) GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis. J. Endocrinol. 201, 219-230.
126. Chu, Z. L., Jones, R. M., He, H., Carroll, C., Gutierrez, V., et al. (2007) A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release. Endocrinology 148, 2601-2609.
127. Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., et al. (2013) Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA 110, 9066-9071.
128. Kalantzi, L., Persson, E., Polentarutti, B., Abrahamsson, B., Goumas, K., et al. (2006) Canine intestinal contents vs. simulated media for the assessment of solubility of two weak bases in the human small intestinal contents. Pharm. Res. 23, 1373-1381.
129. Nyren, R., Chang, C. L., Lindstrom, P., Barmina, A., Vorrsjo, E., et al. (2012) Localization of lipoprotein lipase and GPIHBP1 in mouse pancreas: effects of diet and leptin deficiency. BMC Physiol 12, 14.